Učitavanje...

Pancreatic cancer serum biomarker PC-594: Diagnostic performance and comparison to CA19-9

AIM: To investigate serum PC-594 fatty acid levels as a potential biomarker in North American pancreatic cancer (PaC) patients, and to compare its performance to CA19-9. METHODS: Using tandem mass spectrometry, we evaluated serum PC-594 levels from 84 North American patients with confirmed PaC and 9...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:World J Gastroenterol
Glavni autori: Ritchie, Shawn A, Chitou, Bassirou, Zheng, Qingan, Jayasinghe, Dushmanthi, Jin, Wei, Mochizuki, Asuka, Goodenowe, Dayan B
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2015
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4458770/
https://ncbi.nlm.nih.gov/pubmed/26074698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i21.6604
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!